Eventide Asset Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Eventide Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $3.13 Million - $7.11 Million	-33,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $2.69 Million - $3.9 Million	-13,000 Reduced 28.26%	33,000 $7.07 Million
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $2.13 Million - $6.59 Million	21,000 Added 84.0%	46,000 $12.9 Million
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $2.33 Million - $3.73 Million	25,000 New	25,000 $2.92 Million

298

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.5B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.